Department of Health
and Human Services (HHS)
and Human Services (HHS)
August 3, 2021
PAR-21-253 - Identification and Characterization of Bioactive Microbial Metabolites for Advancing Research on Microbe-Diet-Host Interactions (R01 Clinical Trial Not Allowed)
RFA-DK-21-014 - Identification and Characterization of Bioactive Microbial Metabolites for Advancing Research on Microbe-Diet-Host Interactions Knowledgebase Management Center (U24 Clinical Trial Not Allowed)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
This Notice announces the participation of theEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) in PAR-21-253 “Identification and Characterization of Bioactive Microbial Metabolites for Advancing Research on Microbe-Diet-Host Interactions (R01 Clinical Trial Not Allowed)", effective immediately.
The following sections of PAR-21-253 have been modified (changes shown in bold italics) to reflect the participation of NICHD in this Funding Opportunity Announcement (FOA).
Part 1. Overview Information
Components of Participating Organizations
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute of Environmental Health Sciences (NIEHS)
National Cancer Institute (NCI)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.847, 93.121, 93.113, 93.855, 93.393, 93.396,93.865
Part 2. Full Text of Announcement
Section I. Funding Opportunity Description
NICHD is interested in human studies that address the microbiome and its metabolites in infants who are born preterm or at low birthweights; in child growth and development; in relation to diet and/or nutritional status of children, pregnant individuals or lactating individuals.Additionally, NICHD is interested in the microbiome and its metabolites in gestational diabetes (and risk of gestational diabetes) on pregnancy outcomes and fetal outcomes, and the microbial metabolites of individuals with intellectual or physical disabilities.
Section VII. Agency Contacts
Ashley J, Vargas, PhD, MPH, RDN
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-827-6030
Email:[email protected]
All other aspects of the FOA remain unchanged.
Ashley J, Vargas, PhD, MPH, RDN
Eunice Kennedy ShriverNational Institute of Child Health and Human Development (NICHD)
Telephone: 301-827-6030
Email:[email protected]